Thank you, Mr. Green.
In terms of support for vaccine purchases and so forth, the funding is going to go towards the COVAX facility agreement in securing options to purchase vaccine doses for Canadians as they become available.
The one thing I would say is that authorities typically work within a fiscal year, and viruses and the development of vaccines don't often respect fiscal year-ends. That $1.5 billion you're looking at was given authority by Parliament already last year, but given the delay in the actual payments—